Setterwalls has advised Trill Impact on the deal. Vinge advised Cinclus Pharma.Cinclus Pharma Holding AB, a biopharmaceutical company focused on the development of a novel treatment…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Federica Tiefenthaler
…
This content is for Standard 1 Year members only. LoginJoin Now